Monday, December 8, 2025
News

QDX Congratulates Co-Founder and Head of Research A/Prof. Giuseppe Barca on Receiving the 2025 Dirac Medal

SocialTwist Tell-a-Friend    Print this Page   COMMENT

| May 8, 2025 2:43:49 PM IST
PRNewswire

Singapore, May 8: QDX proudly congratulates its Co-Founder and Head of Research, A/Prof. Giuseppe Barca, on being awarded the 2025 Dirac Medal, the highest international honour for early-career researchers in theoretical and computational chemistry.

Presented by the World Association of Theoretical and Computational Chemists (WATOC), the Dirac Medal recognises scientists under 40 whose research has made exceptional contributions to the field. A/Prof. Barca is recognised for his pioneering work in quantum algorithms and high-performance computing, which has advanced the frontiers of molecular simulation and accelerated applications in drug discovery.

"This is a phenomenal and well-deserved honour for Giuseppe," said Loong Wang, CEO of QDX. "His research continues to redefine what's possible in computational chemistry. This award not only celebrates his individual achievement but also reinforces the bold science that drives QDX."

In addition to his role at QDX, A/Prof. Barca leads the Barca Lab at both the Australian National University and the University of Melbourne, where he develops fast, scalable quantum chemistry methods and algorithms for next-generation computing platforms. His innovations form the core of Rush, QDX's proprietary AI-quantum platform designed to deliver high-precision molecular modelling at cloud scale.

As QDX continues to push the frontier of drug discovery with advanced computational tools, A/Prof. Barca's vision and leadership remain central to its mission to enable and accelerate the discovery of new therapies.

About QDX

QDX is a drug discovery company specializing in high-performance quantum simulations to accelerate the design of new therapeutics. Founded by experts in life science, computational chemistry, and high-performance computing, QDX collaborates with global partners to develop innovative solutions for complex diseases, aiming to transform the landscape of drug discovery. Its flagship platform, Rush, empowers biotech innovators to conduct fast, cost-effective molecular modeling, virtual screening, and predictive analytics--no installation or proprietary hardware required.

Media Contact:

ops@qdx.co

www.qdx.co

(ADVERTORIAL DISCLAIMER: The above press release has been provided by PRNewswire. ANI will not be responsible in any way for the content of the same)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Emergence of India's Next-Generation Tec...
IDFC FIRST Bank launches FIRST WOW! Blac...
Stryder Cycle, a TATA Group Company, Str...
Reliance group unveils new growth engine...
TRAI responds to DoT on satellite-based ...
UN Office Trusts Indian Technology to Fi...
More...
 
INDIA WORLD ASIA
SC seeks Karnataka CM Siddaramaiah's res...
'DMK will face arguments:' DMK MP Kathir...
'Nehru was against this song': Shehzad P...
Family of Delhi tourists killed in Goa C...
Karnataka Dy CM DK Shivakumar arrives at...
PM Modi likely to host special dinner fo...
More...    
 
 Top Stories
MP Congress Chief Jitu Patwari accu... 
SP MP Dimple Yadav flags unemployme... 
Taxpayers' money is being wasted: A... 
US Deputy Ambassador for Trade to v... 
Delhi HC directs Special Committee ... 
IndiGo request more time to respond... 
Punjab: Congress suspends party mem... 
Japan issues tsunami warning after ...